Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 3, 2013Expert Opinion on Investigational Drugs

IL-17 targeted therapies for psoriasis

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAndrea ChiricozziUniversità Cattolica del Sacro Cuore
James G. Krueger
James G. KruegerRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chiricozzi et al. (2013) studied this question.

synapsesocial.com/papers/6a02c64a98cafe0df5755685https://doi.org/10.1517/13543784.2013.806483
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis2010 · 330 citations
  2. 2Interleukin-17/Interleukin-17 Receptor-Mediated Signaling Is Important for Generation of an Optimal Polymorphonuclear Response against<i>Toxoplasma gondii</i>Infection2004 · 350 citations
  3. 3IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis2006 · 687 citations
  4. 4Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis2011 · 321 citations
  5. 5Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up2013 · 415 citations